The Origin and Evolution of SARS Dept. of Microbiology, Faculty of Medicine, The University of Hong Kong The First Affiliated Hospital, Guangzhou Med.

Slides:



Advertisements
Similar presentations
Outbreak Investigation Severe Acute Respiratory Syndrome SARS April 2003.
Advertisements

SARS Cases Worldwide Reported to WHO as of June 6, 2003 China (5329) Singapore (206) Hong Kong (1750) Vietnam (63) Canada (219) U.S. (68) Europe: 8 countries.
The 1 st New Disease of the 21 st Century by Otto Sanchez MD MSc PhD Faculty of Health Sciences University of Ontario Institute of Technology June 2004.
Public health assessment Avian flu A(H5N1) situation Feb 9, 2004.
Research Issues in Animal Surveillance and Pandemic Planning Robert G. Webster, PhD Division of Virology Department of Infectious Diseases St. Jude Children’s.
Laboratory Diagnostics and Specimen Collection. Learning Objectives Know the basic components of specimen collection kits for use with suspect avian influenza.
Severe Acute Respiratory Syndrome
Screening of Human and Animal Sera from Egypt and Hong Kong Perera et al. Euro Surveill. 2013;18(36):pii=20574 Sampled 1343 Human, 625 animals.
Testing algorithms used at Bureau of Labs Michigan Department of Community Health Information on testing algorithms for processing and reporting serological.
Coronaviruses Chapter 40. Structure and Composition Enveloped Spike proteins resemble solar corona or crown nm Positive-strand RNA (27-32 kb)
Control of the H5N1 influenza epidemic at the source Patrick Woo.
Mmmmm Mohamed M. B. Alnoor CHP400 COMMUNITY HEALTH PROGRAM-II Avian Influenza H5N1 Epidemiology & Control mmmmm.
 Refers to an illness caused by any of many different strains of influenza viruses that have adapted to a specific host.  It considers as a flu.  You.
SARS Situation in Guangdong and Hospital Infection Control Xiaoping Tang, M.D, Ph.D Guangzhou No. 8 People’s Hospital.
SARS The Toronto Outbreak April 20, SARS in Toronto I: Index Case February 23 – A 78 year old woman arrives back in Toronto from trip to Hong Kong.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
The Chinese University of Hong Kong Prince of Wales Hospital Role of Convalescence Serum In SARS Patients.
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
1 Module 5 Supplemental Information Laboratory Diagnostics, Specimen Collection, and Biosafety Issues.
AVIANAVIAN FLUFLU Ginny Codd Viruses: Infection and Ecology.
1. 2 Describe this picture? 3 4 Observations are affected by one’s background knowledge and what one wants to see We can describe it as “observations.
DR MOHAMMED ARIF. ASSOCIATE PROFESSOR. CONSULTANT VIROLOGIST. HEAD OF THE VIROLOGY UNIT. Viral infection of the respiratory tract -- 2.
Ethics Conference on Asian Flu Pandemic Ethical considerations among Response to H1N1 Pandemic in China China CDC, CFETP Huilai Ma, Guang Zeng.
How serious is the threat of an Avian flu Human Pandemic Avian (Bird) December 2005.
Human Infection with Avian Influenza A(H7N9) Virus: Situation and Response, China Zijian FENG Center for Public Health Emergency Center Chinese Center.
Laboratory Training for Field Epidemiologists Viral cultures Investigation strategies and methods May 2007.
Biosafety and the Southeast Asian Clinical Infectious Diseases Network (SEAICRN) Rogier van Doorn Clinical Microbiologist Wellcome Trust Major Overseas.
SARS (Severe Acute Respiratory Syndrome) “viral pneumonia” Sejal Patel December 6 th, 2004.
Severe Acute Respiratory Syndrome (SARS) Michael Leonard.
Diseases and the Immune/Lymphatic System. Can you define these terms? Infectious: Capable of spreading disease. Also known as communicable. Virus: A tiny.
Pandemic Influenza. Guidance for Pandemic Influenza: Infection Control in Hospitals and Primary Care Settings UK Pandemic Influenza Contingency Plan Operational.
SARS and Avian Influenza: Public Health Priorities Scott F. Dowell, MD, MPH International Emerging Infections Program Thailand Ministry of Public Health.
NEPAL IS ALSO KNOWN AS. The country of Mount Everest.
Laboratory Issues and West Nile Virus Hema Kapoor MD. SM (NRM)
Diseases and the Immune/Lymphatic System. 5g 5g.
Serum procalcitonin and C-reactive protein in children with community- acquired pneumonia K.Gogvadze, I.Guramishvili, I.Chkhaidze, K.Nemsadze, T.Maglakelidze.
Canine Influenza. Overview Organism History Epidemiology Transmission Disease in Humans Disease in Animals Prevention and Control Center for Food Security.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
Responding to SARS John Watson Health Protection Agency Communicable Disease Surveillance Centre, London.
Update on Assay Development George J. Dawson, Ph.D. Infectious Diseases: Core R & D Abbott Laboratories West Nile Virus.
Dr. Zhen XU Branch of Respiratory Disease Prevention and Control Division for Disease Control and Emergency Response Chinese Center for Disease Control.
Avian Influenza "bird flu" Contagious disease of animals caused by viruses that normally infect only birds and pigs H5N1 can infect people (very rarely)
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Emerging Infectious Diseases: SARS and Avian Influenza Sonja J. Olsen, PhD International Emerging Infections Program Thailand Ministry of Public Health.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Investigation and Control of Outbreaks of Foodborne Illness Ralph Cordell, PhD.
THE SARS VIRUS GENOME The Quick and the Dead?. SARS Severe Acute Respiratory Syndrome First identified in Guangdong Province, China Mortality 3-6% (45-63%
SARS. What is SARS? Severe Acute Respiratory Syndrome Respiratory illness Asia, North America, and Europe Previously unrecognized coronavirus.
Avian Influenza H5N1 Prepared by: Samia ALhabardi.
Experience with SARS Laboratory Diagnostics JSM Peiris, LLM Poon, Y Guan, KH Chan. The University of Hong Kong & Queen Mary Hospital.
SAS-Coronavirus: Diagnosis, Antibody Responses and Biosafty Conserns Cheng Cao Beijing Institute of Biotechnology, China.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
CORONAVIRUSESCORONAVIRUSES Genus Coronavirus CoV& Genus Torovirus.
Viruses causing respiratory infections. Influenza viruses
Genomic Analysis of Wetland Sediment as a Tool for Avian Influenza Virus Surveillance in Wild Waterfowl Chelsea Himsworth DVM, MVetSc, PhD, Dipl ACVP Leader,
Understanding Zoonosis: The Study of Transmissible Diseases and Infections Sarah Ahmed, MD., PhD., George Tarabelsi, MD., Zara Khan, MD., Shubhankar Joshi,
HEPATITIS C VIRUS INFECTION AMONG PATIENTS AT HOSPITAL TENGKU AMPUAN AFZAN, KUANTAN: GENOTYPES DISTRIBUTION AND RNA SEQUENCE VARIATION.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Severe Acute Respiratory Syndrome (SARS) AA Model for Preparedness for Emerging Diseases Finding and Filling Gaps.
SARS Severe Acute Respiratory Syndrome Jeffrey S. Duchin, M.D. Chief, Communicable Disease Control, Epidemiology and Immunization Section, Public Health.
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
1. Globalization High Mobility of Human Globalization of infectious disease outbreaks Lessons from Pandemic (H1N1) 2009 Concern of next pandemic due to.
Director Medical Services (Health) Office of the DGMS (Army)
Special Acknowledgments
Infections and Environmental Interactions: Who is Responsible?
Virus evolution Review Zhao (2007) Philosophical Transactions of the Royal Society B 362: (on VITAL)
1.1.3 MI.
Coronaviruses Co Vs..
Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China by Y. Guan, B. J. Zheng, Y. Q. He, X. L. Liu,
Varicella Vaccine Efficacy Estimates
Presentation transcript:

The Origin and Evolution of SARS Dept. of Microbiology, Faculty of Medicine, The University of Hong Kong The First Affiliated Hospital, Guangzhou Med. College Shenzhen C.D.C. Guangdong Province NIAID, Grant A SARS FUNDS, Univ. of Hong Kong HKU, HK SAR, P.R. China; Sept 30, 2003 Yi Guan

Hypothetical Birthplace of SARS HKU, HK SAR, P.R. China; Sept 30, 2003

Hong Kong 100 miles HKU, HK SAR, P.R. China; Sept 30, 2003 Guangdong Province

Hong Kong 100 miles HKU, HK SAR, P.R. China; Sept 30, 2003 Guangdong Province The First SARS case was recognized on Nov. 16, 2002

Hong Kong 100 miles HKU, HK SAR, P.R. China; Sept 30, 2003 Guangdong Province On Dec 17, 2002, SARS case was observed in the second city. 11 cases were recorded, 8 of them are medical staff

Hong Kong 100 miles HKU, HK SAR, P.R. China; Sept 30, 2003 Guangdong Province The first SARS case in Zhongshan was reported on Dec. 26, Total 28 cases were clinically recognized. 13 of them are medical staff who had direct contact history with SARS patients.

HKU, HK SAR, P.R. China; Sept 30, 2003

Investigation Conclusion 1. Outbreak of atypical pneumonia (unidentified infectious agent, most likely viral infection) 2. Infectious Disease, with family and hospital clustered (incubation about 4 days, 1-11days) 3. Documented Diagnosis definition, Treatment and Prevention principles 4. Suggest to set up case report system Jan. 21, 2003 Zhong-Shan outbreak HKU, HK SAR, P.R. China; Sept 30, 2003

Hong Kong 100 miles HKU, HK SAR, P.R. China; Sept 30, 2003 Guangdong Province The first community SARS case in Guangzhou was reported on Jan.31, 2003.

Visited Zhongshan and got onset there Jan 31, 03: admitted to The 2nd Affiliate Hospital at the afternoon, 30 medical staffs infected Feb 1, 03 - Feb 8, 03: transferred into The 3rd Affiliated Hospital, within those 8 days, 26 medical staffs got infected. Feb 8, 03: transferred into Guangzhou Infectious Disease Hospital. Family members and relatives of the patient also got infected (19). The First “Super-Infectious” case--- >100 cases HKU, HK SAR, P.R. China; Sept 30, 2003

Nov 16, 02 - Feb 9, 03: 305 SARS cases reported, 5 people were killed by the disease in Guangdong City Guangzhou Zhongshan Foshan Jiangmen Heyuen Shenzhen Total No. of case Outbreak time Jan. 31, 2003 Dec. 26, 2002 Nov. 16, 2002 Nil Dec. 17, 2002 Nil HKU, HK SAR, P.R. China; Sept 30, 2003

Peak time of outbreak is on Feb. 9, 50 cases/day Feb. 12, 0330 new cases Feb. 19, 035 new cases No. of reported cases of Guangdong HKU, HK SAR, P.R. China; Sept 30, 2003

HKU started to initiate the investigation in Guangdong as early as on Feb 11, 03. One Big Question: Whether H5N1 bird flu get into humans, like 1997 incident? On Feb 12, 03, we got 18 patients’ samples On Feb 18, 03, we got 22 patients’ samples HKU, HK SAR, P.R. China; Sept 30, 2003

The major efforts were focused on to isolate H5N1 influenza virus We did isolate H5N1 influenza virus from Hong Kong family, and one from Guangzhou atypical pneumonia case We failed to isolate coronavirus earlier, but do benefit to the coming investigation in HK, i.e. our response system started to run before the case got into HK (setting up a lab in Guangzhou) Preliminary results

Isolation of coronavirus by FrHK4 cell cultures GZ43GZ50GZ60 HKU, HK SAR, P.R. China; Sept 30, 2003 Nurse Clerk Doctor

AC BD HKU, HK SAR, P.R. China; Sept 30, 2003

HKU39849 TOR2 HKU Urbani SIN2677 CUHK-Su10 HKU HKU BJ01 CUHK-W1 GZ50 GZ01 GZ60 GZ HKU, HK SAR, P.R. China; Sept 30, 2003

B C D A C

Serological test for pair sera from patients with SARS 19 Total 4 1, I, II, IV < 4 folds , 18, 32, III > 4 folds , 22, 23, 24, 26, 27, 28, 30, 31, 34, V > 4 folds Total Sample number Titer increase 2 nd sera1 st sera HKU, HK SAR, P.R. China; Sept 30, 2003

Where the SARS-Cov came from, Or how it was derived from? What we know, what we don ’ t know and, what studies are needed. Questions????? HKU, HK SAR, P.R. China; Sept 30, 2003

10 NIDOV IBV1 IBV2 TGEV 229E PEDV CUHK HK36 GZ43 GZ50 CAN CDC-USA HK39 BOV1 BOV2 MHV3 MHV1 MHV2 G3 G1 G2 SARS G4? HKU, HK SAR, P.R. China; Sept 30, 2003

l Several observations support the hypothesis of a wild animal reservoir – cases began independently in at least 5 different municipalities – early cases more likely to report living near agricultural market – 39% (9/23) of early cases were food handlers with likely animals contact Observation HKU, HK SAR, P.R. China; Sept 30, 2003

Himalayan palm civet (Paguma larvata) Hog-badger (Arctonyx collaris) Beaver (Castor fiber) Chinese Ferret-Badger (Melogale moschata) Raccoon-dog (Nyctereutes procyonoides) Chinese muntjac (Muntiacus reevesi) Chinese Hare (Lepus sinensis) Domestic cat (Felis catus) Eight species of wild and domestic animals were sampled in a live-animal market of Shenzhen on May 7, 03 HKU, HK SAR, P.R. China; Sept 30, 2003

Animals Human Sampling (nasal, rectal swabs, blood) RT-PCR diagnostic test Virus isolation and identification Sequencing viral genome Sequence comparison Phylogenetic analysis Blood Neutralizing antibody detection Methods Western Blot Assay HKU, HK SAR, P.R. China; Sept 30, 2003

Himalayan palm civet Raccoon-dog Six civets sampled, 4 out of them were PCR positive and 4 viruses were isolated One animal was PCR positive and 1 virus was isolated HKU, HK SAR, P.R. China; Sept 30, 2003

EM Photo of SCoV-like viruses HKU, HK SAR, P.R. China; Sept 30, 2003

1 kb 5 kb10 kb 25 kb 20 kb15 kb 30 kb ORF1a ORF1b S M E N B bp bp bp28100 bp bp bp Human Animal ORF 9 ORF 10 ORF 11 N ORF 13 ORF 9 CCTACTGGTTACCAACCTGAATGGAATAT ORF 10´ N ORF 13 Genome difference between animal and human SARS-Cov Deletion of human virus HKU, HK SAR, P.R. China; Sept 30, 2003

MHV 100 nucleotide SZ1 SZ13 SZ16 SZ3 GZ50 CUHK-W1 HKU36871 HKU39848 HKU66078 HKU65806 Urbani Tor2 GZ01 GZ60 GZ43 Animal Human Phylogenetic analysis of S gene of human and animal SARS viruses HKU, HK SAR, P.R. China; Sept 30, 2003

Detection of antibodies against recombinant nucleocapsid protein of SCoV in animal sera by Western Blot Assay HKU, HK SAR, P.R. China; Sept 30, 2003

Antibody detection from people working at the market HKU, HK SAR, P.R. China; Sept 30, 2003

Summary 1. SCoV-like viruses are prevalent in different types of wild animals in the retail market. 2. These animals together mankind forming a new ecosystem. 3. SARS is zoonosis. HKU, HK SAR, P.R. China; Sept 30, 2003

Need for further animal research l To control SARS we must understand the natural history of the virus l Field and laboratory studies are needed to determine the possible range of animal reservoirs, if there are amplification hosts and how the virus spills over to humans l Control strategies must focus on human and animal populations to be effective HKU, HK SAR, P.R. China; Sept 30, 2003

Acknowledgements 1. NIAID, Grant A Ministry of Health, China Government 3. Guangdong Government 4. Guangdong CDC 5. The First Affiliated Hospital, Guangzhou Medical College 6. Department of Health, Shenzhen Government 7. Shenzhen CDC 8. Department of Microbiology, HKU HKU, HK SAR, P.R. China; Sept 30, 2003